Dr. Rosa Abrantes-Metz Joins BRG As Managing Director of Antitrust and Competition Policy Group

Global expert services and consulting firm (BRG) has announced that Dr. Rosa (Romy) Abrantes-Metz has joined the firm as a managing director in its antitrust and competition policy group. She has over two decades of experience as an economist, consultant and testifying expert and specializes in complex antitrust, securities and financial regulatory matters. She is renowned for her pioneering work using econometric screening techniques to detect conspiracies and market manipulation, most notably in a landmark analysis that uncovered a conspiracy to manipulate the London Interbank Offered Rate (LIBOR) benchmark.

Abrantes-Metz is the latest prominent addition to BRG's world-leading antitrust and competition practice, following the recent appointment of renowned antitrust and platform economics expert Dr. David S. Evans and the September appointment of distinguished antitrust economist Dr. David Sunding. BRG expects to announce further key hires in both the U.S. and Europe in the coming months. Abrantes-Metz is based in New York and joins BRG's office there. Before BRG, she co-chaired the Global Antitrust & Competition and Technology practices of a consulting firm.

Abrantes-Metz's main areas of specialization are econometrics and statistics, industrial organization, and monetary and financial economics. She has particular expertise involving the intersection between alleged market manipulations and competition issues, including alleged coordinated conduct such as collusion and exchanges of information, as well as the economics of multisided platforms. She spearheaded the development and application of empirical screens to detect potential collusion, manipulation and fraud. She has advised agencies across five continents on their adoption of these screens, which are now commonly used worldwide.